URQ-10258-32422
4 vaccinations
2 coded responses
7 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 432 / OH
- Registered
- 2022-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
YB4-21690-01237
Child or adolescent in my care · Male · 2023-03-10
Timeline
-
2021-03-19
Dose 1 — Pfizer-BioNTech
-
2021-04-09
Dose 2 — Pfizer-BioNTech
-
2021-12-07
Dose 3 — Pfizer-BioNTech
-
2022-03-09
Registered in v-safe
- 2022-03-09
-
2022-06-07
Survey response — 6 months, dose 3MedDRA: Delivery — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: Had a baby. Delivered at 35 weeksMedDRA releases: 2024-11 · check-in free text available
-
2022-06-07
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-06-08
-
2022-09-09
Dose 4 — Pfizer-BioNTech
- 2022-10-09
- 2022-10-14
- 2022-10-21
- 2022-12-11
-
2023-03-10
Survey response — 6 months, dose 4MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-10
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-03-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-03-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | No |
| 2 | 2021-04-09 | Pfizer-BioNTech | No |
| 3 | 2021-12-07 | Pfizer-BioNTech | No |
| 4 | 2022-09-09 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-07 | Successful 2023-03-13 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-03-10 | Successful 2023-03-13 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 11 — 6 months, dose 3
Symptoms: Had a baby. Delivered at 35 weeks
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release